期刊文献+

Hpa、uPA 在分化型甲状腺癌组织中表达的临床意义 被引量:2

Expression and clinical significance of Hpa and uPA in thyroid carcinoma
原文传递
导出
摘要 目的:研究乙酰肝素酶( heparanase,Hpa)、尿激酶纤溶酶原激活剂( urokinase type plasmino-gen activator,uPA)在甲状腺癌组织中的表达与淋巴结转移的关系。方法采用免疫组化SP法检测113例甲状腺癌及134例良性甲状腺结节组织中Hpa、uPA蛋白的表达情况,分析Hpa、uPA蛋白在甲状腺癌中表达及其临床意义。结果 Hpa、uPA在甲状腺癌及良性甲状腺结节组织中表达阳性率分别为82.30%、89.38%和16.42%、11.19%,甲状腺癌组织中Hpa、uPA的表达高于良性甲状腺结节(P<0.001)。在甲状腺癌有、无淋巴结转移组Hpa、uPA蛋白表达阳性率分别93.94%、100%和65.96%、74.47%,甲状腺癌组织中有周围淋巴结转移组Hpa、uPA的表达高于无周围淋巴结转移组( P<0.001)。 Hpa、uPA在甲状腺癌组织中的表达成正相关性(r=0.437,P=0.021)。结论 Hpa、uPA检测在甲状腺良恶性肿瘤鉴别诊断、淋巴转移方面有一定的临床价值。 Objective To study the relationship between heparanase( Hpa) , urokinase type plasminogen activator( uPA) expression and lymph node metastasis in thyroid carcinoma.Methods Immunohistochemieal SP method was used to analyze the expression of Hpa and uPA in 113 cases of thyroid carcinoma and 134 cases of be-nign thyroid nodules.The expression of Hpa and uPA in thyroid carcinoma and its clinical significance were ana-lyzed.Results The positive expression rate of Hpa and uPA in thyroid carcinoma and benign nodular thyroid tis-sue were 82.30%,16.42%and 89.38%, 11.19%.The positive expression rate of Hpa and uPA in carcinoma tissues with lymph metastasis and without metastasis were 93.94%,100% and 65.96%,74.47%.Expression of Hpa and uPA in thyroid carcinoma group was significantly higher than that of benign thyroid nodules group( P〈0.001) .The rate of positive expression in lymph metastatic tissues were significantly higher than those in tissue without metastasis( P〈0.001) .Hpa and uPA expression in thyroid carcinoma tissues was positively correlated( r=0.437, P=0.021).Conclusion The expression of Hpa and uPA is closely related with the occurrence and metastasis of thyroid carcinoma.
出处 《中华内分泌外科杂志》 CAS 2015年第3期235-237,249,共4页 Chinese Journal of Endocrine Surgery
基金 连云港帚“科教兴卫工程”青年科技项目(Q1206)
关键词 甲状腺恶性肿瘤 甲状腺良性结节 乙酰肝素酶 尿激酶纤溶酶原激活剂 Thyroid carcinoma Benign thyroid nodules Hpa uPA
  • 相关文献

参考文献9

  • 1李建业,任元满,彭文岗,蔺春芳,张永刚.5-氟尿嘧啶诱导结肠癌细胞凋亡与NF-kB活化及uPA表达的关系[J].肿瘤研究与临床,2007,19(10):658-661. 被引量:3
  • 2李霞,史芳,邱新光,李道明.Annexin II、尿激酶型纤溶酶原激活剂在甲状腺癌中的表达及临床意义[J].中华内分泌外科杂志,2012,6(4):217-220. 被引量:2
  • 3王翠芳.甲状腺癌的诊断、鉴别诊断及预后肿瘤标志物的系列研究[z].辽宁省:沈阳医学院奉天医院.
  • 4Ulisse S, Baldini E, Sorrenti S, et al. High expression of the uro- kinase plasminogen activator and its cognate receptor associates with advanced stages and reduced disease-free interval it* papillary thyroid carcinoma[J]. J Clin Endocrinol Metab,2011,96(2): 504-508.
  • 5Raman K, Kuberan B. Chemical Tumor Biology of Heparan Sul- fate Pmteoglycans[ J]. Curr Chem Biol,2010,4( 1 ) :20-31.
  • 6Ziolkowski AF, Popp SK, Freeman C, et al. Heparan sulfate andheparanase play key roles in mouse [3 cell survival and autoimmune diabetes[J]. J Clin Invest,2012,122( 1 ) :132-141.
  • 7Hoffmann AC, Moil R, Vallbohmer D, et al. High expression of heparanase is significantly associated with dedifferentiafion and lymph node metastasis in patients with pancreatic ductal edenocar- cinomas and correlated to PDGFA and via HIFI a to HB-EGF and bFGF[ J1. J Gastrointest Sura. 2008.12(10) : 1674-1681.
  • 8杨传家.宫建,吴锋,等.乙酰肝素酶在甲状腺乳头状癌淋巴结转移中的作用[D].广西科学,2014.
  • 9Vlodavsky I, Friedmann Y, Elkin M, et al. Mammalian hepara- nase: gene cloning, expression and function in tumor progression and metastasis[J]. Nat Med,|999,5(7):793-802.

二级参考文献19

共引文献3

同被引文献21

  • 1Zheng L, Jiang G, Mei H, et al. Small RNA interference-mediated gene silencing of heparanase abolishes the invasion, metastasis and angiogenesis of gastric cancer cells [J]. BMC Cancer,2010,5 (10):33. DOI:10.1186/1471-2407-10-33.
  • 2Lee TI, Yang HJ, Lin SY, et al.,The accuracy of fine-needle aspi- ration biopsy and frozen section in patients with thyroid cancer[J]. Thyroid,2002,12 (7):619-626. DOI:10.1089/105072502320288492.
  • 3Baloeh ZW, Fleisher S, LiVolsi VA, et al. Diagnosis of "follicular neoplasm": a gray zone in thyroid fine-needle aspiration cytology [J]. Diagn Cytopathol,2002,26(1):41-44. DOI:10.1002/de.10043.
  • 4Alaedeen DI, Khiyami A, MeHenry C1L Fine-needle aspiration biop- sy specimen with a predominance of Htirthle cells: a dilemma in the management of nodular thyroid disease[J]. Surgery,2005,138 (4):650-657. DOI:http://dx.doi.org/10.1016/j.surg.2005.06.047.
  • 5Raman K, Kuberan B. Chemical tumor biology of heparan sulfate proteoglyeans[J]. Curr Chem Biol,2010,4(1):20-31. DOI:10.2174/ 187231310790226206.
  • 6Ziolkowski AF, Popp SK, Freeman C, et al. Heparan sulfate and hep- aranase play key roles in mouse β cell survival and autoimmune di- abetes[J]. J Clin Invest2012,122(1 ):132-141. DOI:10.1172/JCI46177.
  • 7Hoffmann AC, Moil R, Vallbohmer D, et al. High expression of heparanase is significantly associated with dedifferentiation and lymph node metastasis in patients with pancreatic ductal adeno- carcinomas and correlated to PDGFA and via HIFIa to HB-EGF and bFGF[J]. J Gastrointest Surg,2008,12(10):1674-1682. DOI: 10.1007/s 11605-008-0628-2.
  • 8Tang D, Piao Y, Zhao S, et al. Expression and correlation of ma- trix metalloproteinase-9 and heparanase in patients with breast cancer[J].Med Oncol,2014,31 (7):26. DOI:10.1007/s12032-014- 0026-4.
  • 9Zhang W, Yang HC, Wang Q, et al. Clinical value of combined de- tection of serum matrix metalloproteinase-9, heparanase, and cathepsin for determining ovarian cancer invasion and metastasis [J]. Anticancer Res,2011,31 (10) :3423-3428. DOI: 10.1007/sl 1670- 012-0067-1.
  • 10韦露薇,李力,张玮,潘忠勉,姚德生,张洁清.卵巢肿瘤患者外周血乙酰肝素酶测定及临床意义[J].实用妇产科杂志,2011,27(10):762-766. 被引量:2

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部